Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis

Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis

The efficacy of dual antiplatelet therapy (DAPT) for patients with peripheral artery disease (PAD) after lower-limb intervention remains controversial. Currently, the prescription of DAPT after an intervention is not fully recommended in guidelines due to limited evidence. This study compares and an...

Full description

Bibliographic Details
Main Authors: Shang-Yu Tsai, Ying-Sheng Li, Che-Hsiung Lee, Shion-Wei Cha, Yao-Chang Wang, Ta-Wei Su, Sheng-Yueh Yu, Chi-Hsiao Yeh
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceuticals
Subjects:
dual antiplatelet therapy
peripheral artery disease
randomized control trials
major adverse cardiac and cerebrovascular events
major adverse limb events
Online Access:https://www.mdpi.com/1424-8247/15/5/596

Internet

https://www.mdpi.com/1424-8247/15/5/596

Similar Items